| Descriptor English: | Heparin |
| Descriptor Spanish: | Heparina |
| Descriptor Portuguese: | Heparina |
| Descriptor French: | Héparine |
| Entry term(s): |
Heparin Sodium Heparin, Sodium Heparin, Unfractionated Heparinic Acid Liquaemin Sodium Heparin Unfractionated Heparin alpha Heparin alpha-Heparin |
| Tree number(s): |
D09.698.373.400 |
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D006493 |
| Scope note: | A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. |
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
| Entry Combination: |
antagonists & inhibitors:Heparin Antagonists
|
| Pharm Action: |
Anticoagulants Fibrinolytic Agents |
| Registry Number: | 9005-49-6 |
| Public MeSH Note: | /therapeutic use was HEPARIN, THERAPEUTIC 1965 |
| History Note: | /therapeutic use was HEPARIN, THERAPEUTIC 1965 |
| DeCS ID: | 23279 |
| Unique ID: | D006493 |
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents |
| Date Established: | 1960/01/01 |
| Date of Entry: | 1999/01/01 |
| Revision Date: | 2010/06/25 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
|
Heparin
- Preferred
Liquaemin
- Narrower
Sodium Heparin
- Narrower
alpha-Heparin
- Narrower
| Concept UI |
M0010187 |
| Scope note | A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. |
| Preferred term | Heparin |
| Entry term(s) |
Heparin, Unfractionated Heparinic Acid Unfractionated Heparin |
| Concept UI |
M0376235 |
| Preferred term | Liquaemin |
| Concept UI |
M0010188 |
| Preferred term | Sodium Heparin |
| Entry term(s) |
Heparin Sodium Heparin, Sodium |
| Concept UI |
M0010189 |
| Preferred term | alpha-Heparin |
| Entry term(s) |
alpha Heparin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
